학술논문
T1397 A Novel, Oral 5HT3 Partial Agonist, DDP733, Improves Overall Response in Patients with Irritable Bowel Syndrome and Constipation (IBS-c): A Randomized, Double Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study.
Document Type
Abstract
Author
Source
Gastroenterology (00165085); Apr2008 Supplement 1, Vol. 134 Issue 4, pA-547, 0p
Subject
Language
ISSN
00165085